Breaking News Instant updates and real-time market news.

EDR

Endeavor Group

$28.54 /

-1.285 (-4.31%)

12:22
01/25/22
01/25
12:22
01/25/22
12:22

Jake Paul announces stake in Endeavor Group, contacts Engine No. 1

Social media personality and professional boxer Jake Paul announced earlier via Twitter that he's investing in Endeavor Group, the parent of the Ultimate Fighting Championship. He added that he's reaching out to activist Engine No. 1 regarding the stake. Paul tweeted: "I've invested in EDR (UFC) stock with my partner @geoffreywoo 2 focus on UFCs ESG standards relating to fighters. We believe EDR can drive long-term economic value by increasing UFC fighter pay & providing them healthcare. Reaching out to @EngineNo_1 to partner on this "endeavor."

  • 29

    Apr

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Cathie Wood's ARK Investment bought 268.7K shares of TuSimple today  20:08
07/06/22
07/06
20:08
07/06/22
20:08
TSP

TuSimple

$7.74 /

-0.215 (-2.70%)

 
ShowHide Related Items >><<
TSP TuSimple
$7.74 /

-0.215 (-2.70%)

TSP TuSimple
$7.74 /

-0.215 (-2.70%)

05/26/22 China Renaissance
TuSimple upgraded to Buy from Hold at China Renaissance
05/13/22 RBC Capital
TuSimple downgraded to Sector Perform from Outperform at RBC Capital
05/13/22 RBC Capital
TuSimple downgraded to Sector Perform from Outperform at RBC Capital
05/12/22 KeyBanc
TuSimple price target lowered to $30 from $40 at KeyBanc
TSP TuSimple
$7.74 /

-0.215 (-2.70%)

TSP TuSimple
$7.74 /

-0.215 (-2.70%)

TSP TuSimple
$7.74 /

-0.215 (-2.70%)

TSP TuSimple
$7.74 /

-0.215 (-2.70%)

Hot Stocks
Cathie Wood's ARK Investment bought 223K shares of Shopify today  20:07
07/06/22
07/06
20:07
07/06/22
20:07
SHOP

Shopify

$32.99 /

-1.02 (-3.00%)

 
ShowHide Related Items >><<
SHOP Shopify
$32.99 /

-1.02 (-3.00%)

SHOP Shopify
$32.99 /

-1.02 (-3.00%)

07/06/22 Oppenheimer
Shopify target adjusted to $50 for stock split at Oppenheimer
07/05/22 Truist
Shopify price target lowered to $35 from $450 at Truist
07/05/22 JMP Securities
Shopify initiated with a Market Perform at JMP Securities
06/29/22 Stifel
Shopify price target adjusted to $65 at Stifel to reflect split
SHOP Shopify
$32.99 /

-1.02 (-3.00%)

SHOP Shopify
$32.99 /

-1.02 (-3.00%)

SHOP Shopify
$32.99 /

-1.02 (-3.00%)

SHOP Shopify
$32.99 /

-1.02 (-3.00%)

Hot Stocks
Cathie Wood's ARK Investment bought 129.5K shares of Block today  20:07
07/06/22
07/06
20:07
07/06/22
20:07
SQ

Block

$64.99 /

-1.75 (-2.62%)

 
ShowHide Related Items >><<
SQ Block
$64.99 /

-1.75 (-2.62%)

SQ Block
$64.99 /

-1.75 (-2.62%)

06/30/22 Truist
Block price target lowered to $105 from $145 at Truist
06/17/22 Mizuho
Marqeta has negotiating leverage with Square, says Mizuho
06/15/22 Credit Suisse
Block price target lowered to $170 from $180 at Credit Suisse
06/07/22 Mizuho
PayPal sales could rise 20% if Apple enables Venmo tap, says Mizuho
SQ Block
$64.99 /

-1.75 (-2.62%)

SQ Block
$64.99 /

-1.75 (-2.62%)

SQ Block
$64.99 /

-1.75 (-2.62%)

SQ Block
$64.99 /

-1.75 (-2.62%)

Hot Stocks
Cathie Wood's ARK Investment bought 120.5K shares of Twilio today  20:06
07/06/22
07/06
20:06
07/06/22
20:06
TWLO

Twilio

$88.69 /

-1.81 (-2.00%)

 
ShowHide Related Items >><<
TWLO Twilio
$88.69 /

-1.81 (-2.00%)

TWLO Twilio
$88.69 /

-1.81 (-2.00%)

06/09/22 Scotiabank
Scotiabank starts Twilio at Outperform with $215 price target
06/08/22 Scotiabank
Twilio initiated with an Outperform at Scotiabank
06/02/22 Barclays
Twilio downgraded to Equal Weight from Overweight at Barclays
05/23/22 Jefferies
Twilio price target lowered to $130 from $175 at Jefferies
TWLO Twilio
$88.69 /

-1.81 (-2.00%)

TWLO Twilio
$88.69 /

-1.81 (-2.00%)

TWLO Twilio
$88.69 /

-1.81 (-2.00%)

Hot Stocks
Cathie Wood's ARK Investment bought 241K shares of Coinbase today  20:06
07/06/22
07/06
20:06
07/06/22
20:06
COIN

Coinbase

$51.69 /

-3.695 (-6.67%)

 
ShowHide Related Items >><<
COIN Coinbase
$51.69 /

-3.695 (-6.67%)

COIN Coinbase
$51.69 /

-3.695 (-6.67%)

07/06/22 Atlantic Equities
Atlantic downgrades Coinbase to Neutral, lowers price target 'materially'
07/06/22 Atlantic Equities
Coinbase downgraded to Neutral from Overweight at Atlantic Equities
06/27/22 Goldman Sachs
Coinbase downgraded to Sell from Neutral at Goldman Sachs
06/23/22 Redburn
Coinbase downgraded to Neutral from Buy at Redburn
COIN Coinbase
$51.69 /

-3.695 (-6.67%)

COIN Coinbase
$51.69 /

-3.695 (-6.67%)

COIN Coinbase
$51.69 /

-3.695 (-6.67%)

COIN Coinbase
$51.69 /

-3.695 (-6.67%)

Earnings
Samsung sees Q2 operating profit KRW14.0T vs. KRW14.6T consensus » 19:44
07/06/22
07/06
19:44
07/06/22
19:44
SSNLF

Samsung

$57.75 /

+ (+0.00%)

Sees Q2 revenue KRW77.0T,…

Sees Q2 revenue KRW77.0T, up 21% y/y. Consensus estimates are according to Bloomberg.

ShowHide Related Items >><<
SSNLF Samsung
$57.75 /

+ (+0.00%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

06/22/22 Loop Capital
Samsung initiated with a Buy at Loop Capital
06/13/22 KeyBanc
Qualcomm price target raised to $220 from $200 at KeyBanc
06/13/22 UBS
Micron price target lowered to $115 from $120 at UBS
06/01/22 Craig-Hallum
Ambarella price target lowered to $100 from $170 at Craig-Hallum
SSNLF Samsung
$57.75 /

+ (+0.00%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

SSNLF Samsung
$57.75 /

+ (+0.00%)

Initiation
Munich Re initiated with a Sector Perform at RBC Capital » 19:40
07/06/22
07/06
19:40
07/06/22
19:40
MURGY

Munich Re

$22.49 /

+0.06 (+0.27%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MURGY Munich Re
$22.49 /

+0.06 (+0.27%)

04/25/22 UBS
Munich Re price target raised to EUR 270 from EUR 266 at UBS
04/20/22 Barclays
Munich Re price target lowered to EUR 291 from EUR 299 at Barclays
04/05/22 Morgan Stanley
Munich Re downgraded to Equal Weight from Overweight at Morgan Stanley
03/29/22 Societe Generale
Munich Re upgraded to Buy from Hold at Societe Generale
Initiation
Swiss Re initiated with a Sector Perform at RBC Capital » 19:37
07/06/22
07/06
19:37
07/06/22
19:37
SSREY

Swiss Re

$18.39 /

-0.19 (-1.02%)

RBC Capital analyst…

RBC Capital analyst Derald Goh initiated coverage of Swiss Re with a Sector Perform rating and CHF 80 price target. The company's P&C operations have shown good signs of a turnaround in 2021 and its ROE is expected to grow from 9% to 15% in 2023e, but the group's history of higher earnings volatility relative to peers remains a reason for caution, the analyst tells investors in a research note.

ShowHide Related Items >><<
SSREY Swiss Re
$18.39 /

-0.19 (-1.02%)

SSREY Swiss Re
$18.39 /

-0.19 (-1.02%)

07/01/22 Barclays
Swiss Re downgraded to Equal Weight from Overweight at Barclays
06/14/22 HSBC
Swiss Re downgraded to Hold from Buy at HSBC
05/09/22 Morgan Stanley
Swiss Re price target lowered to CHF 85 from CHF 95 at Morgan Stanley
05/09/22 Oddo BHF
Swiss Re upgraded to Outperform from Neutral at Oddo BHF
SSREY Swiss Re
$18.39 /

-0.19 (-1.02%)

Initiation
Hannover Re initiated with an Outperform at RBC Capital » 19:35
07/06/22
07/06
19:35
07/06/22
19:35
HVRRY

Hannover Re

$69.34 /

+0.735 (+1.07%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HVRRY Hannover Re
$69.34 /

+0.735 (+1.07%)

05/11/22 Morgan Stanley
Hannover Re price target raised to EUR 180 from EUR 179 at Morgan Stanley
05/05/22 Credit Suisse
Hannover Re price target raised to EUR 174 from EUR 165 at Credit Suisse
04/20/22 Barclays
Hannover Re price target lowered to EUR 138.80 from EUR 145.70 at Barclays
04/05/22 Morgan Stanley
Hannover Re price target lowered to EUR 179 from EUR 201 at Morgan Stanley
Initiation
Scor initiated with an Outperform at RBC Capital » 19:32
07/06/22
07/06
19:32
07/06/22
19:32
SCRYY

Scor

$1.89 /

+0.02 (+1.07%)

RBC Capital analyst…

RBC Capital analyst Derald Goh initiated coverage of Scor with an Outperform rating and EUR 26 price target. The company's weak headline earnings are a "deterrent", but its underlying metrics continue to improve, the analyst tells investors in a research note, adding that at 5-times forward earnings, the valuation disconnect on the stock is "too wide".

ShowHide Related Items >><<
SCRYY Scor
$1.89 /

+0.02 (+1.07%)

10:14 Today JPMorgan
Scor price target lowered to EUR 24.50 from EUR 28 at JPMorgan
06/14/22 HSBC
Scor downgraded to Hold from Buy at HSBC
05/12/22 UBS
Scor price target raised to EUR 35.10 from EUR 33 at UBS
05/09/22 JPMorgan
Scor price target raised to EUR 28 from EUR 27.50 at JPMorgan
On The Fly
Fly Intel: After-Hours Movers » 19:17
07/06/22
07/06
19:17
07/06/22
19:17
VERU

Veru

$13.03 /

+1.52 (+13.21%)

, GME

GameStop

$117.34 /

-2.82 (-2.35%)

, SPCE

Virgin Galactic

$6.44 /

-0.045 (-0.69%)

, DMAC

DiaMedica Therapeutics

$2.03 /

+ (+0.00%)

, CTMX

CytomX Therapeutics

$1.96 /

+0.015 (+0.77%)

, USNA

Usana

$76.42 /

+1.4 (+1.87%)

, NAPA

Duckhorn Portfolio

$20.72 /

-0.45 (-2.13%)

Check out this evening's…

ShowHide Related Items >><<
VERU Veru
$13.03 /

+1.52 (+13.21%)

SPCE Virgin Galactic
$6.44 /

-0.045 (-0.69%)

NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

GME GameStop
$117.34 /

-2.82 (-2.35%)

DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

VERU Veru
$13.03 /

+1.52 (+13.21%)

16:31 Today Jefferies
Veru data likely portend FDA authorization in 30 days, says Jefferies
05/18/22 Brookline
Veru price target raised to $31 from $29 at Brookline
05/13/22 Jefferies
Veru price target raised to $55 from $33 at Jefferies
04/12/22 Oppenheimer
Veru price target raised to $36 from $25 at Oppenheimer
GME GameStop
$117.34 /

-2.82 (-2.35%)

05/26/22 Wedbush
Wedbush keeps Underperform on GameStop citing valuation and cash burn concerns
03/28/22 B. Riley
Bed Bath & Beyond price target raised to $26 from $19 at B. Riley
03/18/22 Wedbush
GameStop price target lowered to $30 from $45 at Wedbush
03/08/22 BofA
Bed Bath's buybuy BABY 'not worth' several billion dollars, says BofA
SPCE Virgin Galactic
$6.44 /

-0.045 (-0.69%)

06/21/22 Wells Fargo
Virgin Galactic initiated with an Underweight at Wells Fargo
05/09/22 Truist
Virgin Galactic downgraded to Hold from Buy at Truist
05/09/22 Truist
Virgin Galactic downgraded to Hold from Buy at Truist
05/06/22 Canaccord
Virgin Galactic downgraded to Hold at Canaccord after commercial launch delay
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

06/23/22 BMO Capital
CytomX Therapeutics initiated with an Outperform at BMO Capital
05/27/22 Piper Sandler
CytomX Therapeutics price target lowered to $10 from $16 at Piper Sandler
01/18/22 Barclays
CytomX Therapeutics upgraded to Overweight from Underweight at Barclays
12/22/21 H.C. Wainwright
CytomX Therapeutics price target lowered to $11 from $12 at H.C. Wainwright
USNA Usana
$76.42 /

+1.4 (+1.87%)

04/27/22 DA Davidson
Usana price target lowered to $76 from $86 at DA Davidson
04/14/22 DA Davidson
DA Davidson starts Usana at Neutral, expects further sales decline due to COVID
04/13/22 DA Davidson
Usana initiated with a Neutral at DA Davidson
10/08/21 Tigress Financial
Usana shares have 27% upside in 12 months, says Tigress Financial
NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

06/06/22 Barclays
Duckhorn Portfolio price target raised to $21 from $20 at Barclays
03/28/22 RBC Capital
Duckhorn Portfolio upgraded to Outperform from Sector Perform at RBC Capital
03/10/22 Barclays
Duckhorn Portfolio price target lowered to $19 from $22 at Barclays
12/17/21 JPMorgan
JPMorgan announces top 2022 stock picks in beverages, personal care
VERU Veru
$13.03 /

+1.52 (+13.21%)

USNA Usana
$76.42 /

+1.4 (+1.87%)

SPCE Virgin Galactic
$6.44 /

-0.045 (-0.69%)

NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

GME GameStop
$117.34 /

-2.82 (-2.35%)

DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

CTMX CytomX Therapeutics
$1.96 /

+0.015 (+0.77%)

  • 07
    Jul
  • 15
    Oct
VERU Veru
$13.03 /

+1.52 (+13.21%)

GME GameStop
$117.34 /

-2.82 (-2.35%)

VERU Veru
$13.03 /

+1.52 (+13.21%)

USNA Usana
$76.42 /

+1.4 (+1.87%)

SPCE Virgin Galactic
$6.44 /

-0.045 (-0.69%)

GME GameStop
$117.34 /

-2.82 (-2.35%)

DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

VERU Veru
$13.03 /

+1.52 (+13.21%)

SPCE Virgin Galactic
$6.44 /

-0.045 (-0.69%)

GME GameStop
$117.34 /

-2.82 (-2.35%)

Hot Stocks
TransMedics director sells $1.7M in common stock » 18:50
07/06/22
07/06
18:50
07/06/22
18:50
TMDX

TransMedics

$33.41 /

-1.74 (-4.95%)

In a regulatory filing,…

In a regulatory filing, TransMedics disclosed that its director James Tobin sold 48.5K shares of common stock o July 5th in a total transaction size of $1.7M.

ShowHide Related Items >><<
TMDX TransMedics
$33.41 /

-1.74 (-4.95%)

TMDX TransMedics
$33.41 /

-1.74 (-4.95%)

06/28/22 Cowen
TransMedics price target raised to $39 from $35 at Cowen
05/04/22 Canaccord
TransMedics price target raised to $46 from $39 at Canaccord
05/04/22 Cowen
TransMedics price target raised to $35 from $28 at Cowen
03/17/22 Canaccord
TransMedics price target raised to $39 from $38 at Canaccord
TMDX TransMedics
$33.41 /

-1.74 (-4.95%)

Hot Stocks
LGI Homes reports 627 homes closed in June » 18:47
07/06/22
07/06
18:47
07/06/22
18:47
LGIH

LGI Homes

$98.43 /

-1.44 (-1.44%)

LGI Homes "announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGIH LGI Homes
$98.43 /

-1.44 (-1.44%)

LGIH LGI Homes
$98.43 /

-1.44 (-1.44%)

04/20/22 BTIG
LGI Homes upgraded to Neutral from Sell at BTIG
04/13/22 JPMorgan
LGI Homes price target lowered to $81 from $96 at JPMorgan
03/23/22 BTIG
BTIG cuts LGI Homes to Sell given its reliance on single-family rental investors
03/23/22 BTIG
LGI Homes downgraded to Sell from Neutral at BTIG
LGIH LGI Homes
$98.43 /

-1.44 (-1.44%)

LGIH LGI Homes
$98.43 /

-1.44 (-1.44%)

Hot Stocks
Asur reports June traffic up 23.1% y/y, up 16.9% y/y from 2019 » 17:54
07/06/22
07/06
17:54
07/06/22
17:54
ASR

Asur

$194.30 /

+2.5 (+1.30%)

Grupo Aeroportuario del…

Grupo Aeroportuario del Sureste "announced that passenger traffic for June 2022 reached a total of 5.6 million passengers, 16.9% above the levels reported in Jun 2019 and up 23.1% y/y. Compared to June 2019, passenger traffic increased by 40.1% in Colombia, 11.5% in Mexico and Puerto Rico 7.2%. Passenger traffic growth in Mexico and Colombia was driven by both domestic and international traffic, and in Puerto Rico mainly domestic traffic, while international traffic continued to gradually recover."

ShowHide Related Items >><<
ASR Asur
$194.30 /

+2.5 (+1.30%)

ASR Asur
$194.30 /

+2.5 (+1.30%)

02/08/22 Bradesco BBI
Asur downgraded to Neutral from Outperform at Bradesco BBI
11/30/21 Goldman Sachs
Asur upgraded to Neutral from Sell at Goldman Sachs
11/30/21 Goldman Sachs
OMA upgraded to Buy from Neutral at Goldman Sachs
10/13/21 Citi
Asur price target raised to $218 from $191 at Citi
Hot Stocks
Volaris reports June traffic results up 11% year-over-year » 17:34
07/06/22
07/06
17:34
07/06/22
17:34
VLRS

Volaris

$9.67 /

-0.105 (-1.07%)

Volaris reports June 2022…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VLRS Volaris
$9.67 /

-0.105 (-1.07%)

VLRS Volaris
$9.67 /

-0.105 (-1.07%)

06:28 Today Barclays
Volaris price target lowered to $16 from $27 at Barclays
06/27/22 Evercore ISI
Volaris price target lowered to $20 from $30 at Evercore ISI
06/06/22 JPMorgan
Volaris initiated with an Overweight at JPMorgan
02/23/22 Barclays
Volaris price target raised to $27 from $25 at Barclays
VLRS Volaris
$9.67 /

-0.105 (-1.07%)

  • 06
    Aug
Hot Stocks
General Dynamics awarded $145.47M Defense Logistics Agency contract » 17:19
07/06/22
07/06
17:19
07/06/22
17:19
GD

General Dynamics

$219.52 /

+5.235 (+2.44%)

General Dynamics has been…

General Dynamics has been awarded a maximum $145.47M firm-fixed-price, indefinite-delivery/definite-quantity contract for multiple spare parts in the Abrams Main Battle Tank, Stryker Family of Vehicles, Light Armored Vehicle Family of Vehicles, Cougar, Buffalo and RG-31. This was a sole-source acquisition using justification 10 U.S. Code 2304, as stated in Federal Acquisition Regulation 6.302-1. This is a five-year contract with no option periods. Location of performance is Florida, with a July 29, 2029, delivery completion date. Using military service is Army. Type of appropriation is fiscal 2022 through 2027 Army working capital funds. The contracting activity is the Defense Logistics Agency.

ShowHide Related Items >><<
GD General Dynamics
$219.52 /

+5.235 (+2.44%)

GD General Dynamics
$219.52 /

+5.235 (+2.44%)

04/28/22 Susquehanna
General Dynamics price target raised to $285 from $280 at Susquehanna
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
03/07/22 Wells Fargo
General Dynamics price target raised to $282 from $235 at Wells Fargo
02/04/22 Morgan Stanley
Morgan Stanley upgrades General Dynamics to Equal Weight on Gulfstream outlook
GD General Dynamics
$219.52 /

+5.235 (+2.44%)

GD General Dynamics
$219.52 /

+5.235 (+2.44%)

GD General Dynamics
$219.52 /

+5.235 (+2.44%)

Hot Stocks
DiaMedica Therapeutics down 38% to $1.25 after placing DM199 on clinical hold  17:13
07/06/22
07/06
17:13
07/06/22
17:13
DMAC

DiaMedica Therapeutics

$2.03 /

+ (+0.00%)

 
ShowHide Related Items >><<
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

Hot Stocks
Shore Bancshares authorizes up to $5M stock buyback » 17:09
07/06/22
07/06
17:09
07/06/22
17:09
SHBI

Shore Bancshares

$18.53 /

-0.02 (-0.11%)

Shore Bancshares…

Shore Bancshares announced that it had received a non-objection letter from the Federal Reserve Bank of Richmond to allow the Board to authorize management to repurchase its common stock. Under the new repurchase program, management is authorized to repurchase up to $5M, or approximately 1.4% of the 19.8M outstanding shares of the company's common stock. The program may be limited or terminated at any time without prior notice. The program will expire on March 31, 2023. Lloyd L. "Scott" Beatty, Jr., President and Chief Executive Officer stated, "We general like to have an active stock buyback program in place at any given time. Our last stock buyback program proved to be very effective before it expired at the end of 2021. With the current volatility in the financial markets and the unknown with the current economy, we deem it prudent to have an active buyback in place in the event we can purchase our common stock at a discount. Our strong capital levels and solid operating results provide us the flexibility to repurchase shares, which is an efficient way to deploy capital, creating long-term shareholder value."

ShowHide Related Items >><<
SHBI Shore Bancshares
$18.53 /

-0.02 (-0.11%)

11/04/21 Piper Sandler
Shore Bancshares upgraded to Overweight from Neutral at Piper Sandler
SHBI Shore Bancshares
$18.53 /

-0.02 (-0.11%)

Syndicate
Oil States files to sell 1.9M shares of common stock for holders  17:08
07/06/22
07/06
17:08
07/06/22
17:08
OIS

Oil States

$4.68 /

-0.23 (-4.68%)

 
ShowHide Related Items >><<
OIS Oil States
$4.68 /

-0.23 (-4.68%)

OIS Oil States
$4.68 /

-0.23 (-4.68%)

04/18/22 Piper Sandler
Oil States price target raised to $10 from $8 at Piper Sandler
03/07/22 Piper Sandler
Oil States upgraded to Overweight with 45% upside at Piper Sandler
03/04/22 Piper Sandler
Oil States upgraded to Overweight from Neutral at Piper Sandler
OIS Oil States
$4.68 /

-0.23 (-4.68%)

Hot Stocks
China Green removed from NYSE late filers list following quarterly report » 17:02
07/06/22
07/06
17:02
07/06/22
17:02
CGA

China Green

$5.26 /

-0.885 (-14.41%)

China Green announced…

China Green announced that the company received a notice letter from the NYSE stating that, effective July 5, the company will be removed from NYSE's late filers' list to be disseminated to data vendors and will not be posted on the NYSE's Listed Standards Filing Status page. The NYSE's letter comes after the company filed its quarterly report on Form 10-Q for the period ended March 31, thus becoming current on its financial reporting obligations.

ShowHide Related Items >><<
CGA China Green
$5.26 /

-0.885 (-14.41%)

Hot Stocks
Blackstone announces $400M investment in Xpansiv » 17:01
07/06/22
07/06
17:01
07/06/22
17:01
BX

Blackstone

$93.96 /

-0.005 (-0.01%)

Blackstone…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BX Blackstone
$93.96 /

-0.005 (-0.01%)

BX Blackstone
$93.96 /

-0.005 (-0.01%)

05/19/22 Deutsche Bank
Blackstone price target lowered to $180 from $182 at Deutsche Bank
04/27/22 Argus
American Campus downgraded to Hold from Buy at Argus
04/22/22 BMO Capital
Blackstone price target raised to $142 from $124 at BMO Capital
04/22/22 Deutsche Bank
Blackstone price target lowered to $182 from $186 at Deutsche Bank
BX Blackstone
$93.96 /

-0.005 (-0.01%)

  • 08
    Dec
BX Blackstone
$93.96 /

-0.005 (-0.01%)

BX Blackstone
$93.96 /

-0.005 (-0.01%)

BX Blackstone
$93.96 /

-0.005 (-0.01%)

Hot Stocks
DiaMedica Therapeutics trading resumes  17:00
07/06/22
07/06
17:00
07/06/22
17:00
DMAC

DiaMedica Therapeutics

$2.03 /

+ (+0.00%)

 
ShowHide Related Items >><<
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

Syndicate
Duckhorn Portfolio offers to sell 5M shares of common stock for holder » 16:56
07/06/22
07/06
16:56
07/06/22
16:56
NAPA

Duckhorn Portfolio

$20.72 /

-0.45 (-2.13%)

The Duckhorn Portfolio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

06/06/22 Barclays
Duckhorn Portfolio price target raised to $21 from $20 at Barclays
03/28/22 RBC Capital
Duckhorn Portfolio upgraded to Outperform from Sector Perform at RBC Capital
03/10/22 Barclays
Duckhorn Portfolio price target lowered to $19 from $22 at Barclays
12/17/21 JPMorgan
JPMorgan announces top 2022 stock picks in beverages, personal care
NAPA Duckhorn Portfolio
$20.72 /

-0.45 (-2.13%)

  • 15
    Oct
Hot Stocks
Kilroy Realty announces new onsite solar projects in California » 16:54
07/06/22
07/06
16:54
07/06/22
16:54
KRC

Kilroy Realty

$53.50 /

-1.1 (-2.01%)

Kilroy Realty…

Kilroy Realty "announced today that it has completed three onsite solar installations at 2100 Kettner and 9455 Towne Centre Drive in San Diego and Kilroy Oyster Point - Phase 1 in South San Francisco. With these systems energized, Kilroy now hosts over six megawatts of solar spanning across 13 assets, demonstrating Kilroy's continued commitment to scaling its renewable energy installations throughout its California portfolio. "

ShowHide Related Items >><<
KRC Kilroy Realty
$53.50 /

-1.1 (-2.01%)

KRC Kilroy Realty
$53.50 /

-1.1 (-2.01%)

06:41 Today Mizuho
Kilroy Realty price target lowered to $60 from $77 at Mizuho
07/05/22 RBC Capital
Kilroy Realty price target lowered to $68 from $80 at RBC Capital
06/30/22 Jefferies
Kilroy Realty price target lowered to $58 from $76 at Jefferies
06/22/22 Credit Suisse
Kilroy Realty initiated with an Underperform at Credit Suisse
KRC Kilroy Realty
$53.50 /

-1.1 (-2.01%)

KRC Kilroy Realty
$53.50 /

-1.1 (-2.01%)

Hot Stocks
DiaMedica Therapeutics to resume trading at 17:00ET  16:49
07/06/22
07/06
16:49
07/06/22
16:49
DMAC

DiaMedica Therapeutics

$2.03 /

+ (+0.00%)

 
ShowHide Related Items >><<
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

DMAC DiaMedica Therapeutics
$2.03 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.